About Uncharacterized protein C11orf24
Uncharacterized protein C11orf24 (C11orf24) is a protein
from Homo sapiens identified by UniProt accession
Q96F05, 449 residues long.
MolForge cross-references it against 0 known binders and
19 disease associations.
Target properties
| Protein name | Uncharacterized protein C11orf24 |
| UniProt accession | Q96F05 |
| Gene | C11orf24 |
| Organism | Homo sapiens |
| Length | 449 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (19)
Diseases linked to this target (Open Targets).
- BMI-adjusted waist-hip ratio · score 0.36
- systolic blood pressure · score 0.16
- appendicular lean mass · score 0.15
- body height · score 0.13
- urate measurement · score 0.06
- heel bone mineral density · score 0.05
- sitting height measurement · score 0.05
- mean reticulocyte volume · score 0.04
- bone quantitative ultrasound measurement · score 0.04
- bone density · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96F05-F1 | alphafold | PREDICTED | 51.54 | — |
Amino-acid sequence (449 residues)
MWTALVLIWI FSLSLSESHA ASNDPRNFVP NKMWKGLVKR NASVETVDNK TSEDVTMAAA SPVTLTKGTS AAHLNSMEVT TEDTSRTDVS EPATSGGAAD GVTSIAPTAV ASSTTAASIT TAASSMTVAS SAPTTAASST TVASIAPTTA ASSMTAASST PMTLALPAPT STSTGRTPST TATGHPSLST ALAQVPKSSA LPRTATLATL ATRAQTVATT ANTSSPMSTR PSPSKHMPSD TAASPVPPMR PQAQGPISQV SVDQPVVNTT NKSTPMPSNT TPEPAPTPTV VTTTKAQARE PTASPVPVPH TSPIPEMEAM SPTTQPSPMP YTQRAAGPGT SQAPEQVETE ATPGTDSTGP TPRSSGGTKM PATDSCQPST QGQYMVVTTE PLTQAVVDKT LLLVVLLLGV TLFITVLVLF ALQAYESYKK KDYTQVDYLI NGMYADSEM
Explore Uncharacterized protein C11orf24 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets